|
from: Taylor & Francis
List Price: $44.95Amazon.com's Price: $35.96 You Save: $8.99 (20%)Prices subject to change. Availability: Usually ships in 24 hours
Binding: Kindle Edition
Dewey Decimal Number: 616
Format: Kindle Book
Label: Taylor & Francis
Manufacturer: Taylor & Francis
Number Of Items: 1
Number Of Pages: 336
Publication Date: April 16, 2007
Publisher: Taylor & Francis
Release Date: April 16, 2007
Sales Rank: 65348
Studio: Taylor & Francis
Editorial Review:
Product Description:
The introduction of TNF-a blocking agents is one of the milestones in the therapy of rheumatoid arthritis, parallel to the introduction of cortico-steroids. Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, the book charts the history and development of the concept of tumor-necrosis-factor-alpha (TNF-a) inhibition. The authors document TNF-a from its discovery to its now well-documented clinical applications in the treatment of patients with rheumatoid arthritis. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source for the most recent information in this field.
|
